NCR1 and cranioectodermal dysplasia: A diagnostic biomarker NKp46, belonging to the NK receptors (NKRs), has been recently proposed to differentiate RCD2 from RCD 1 since it was found to be significantly more expressed by malignant RCD2 IELs than normal IELs in CeD and RCD1 [48].